{"content":"<li class=\"n-box-item date-title\" data-end=\"1570161599\" data-start=\"1570075200\" data-txt=\"Monday, December 23, 2019\">Thursday, October  3, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3503912\" data-ts=\"1570145144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503912-hp-to-cut-up-to-9k-jobs-in-restructuring-guides-2020-eps-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP to cut up to 9K jobs in restructuring; guides 2020 EPS below consensus</a></h4><ul><li>HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) announces a <a href=\"https://seekingalpha.com/pr/17653466-hp-inc-announces-fiscal-2020-financial-outlook-and-restructuring-plan\" target=\"_blank\">major restructuring</a> that will include the elimination of 7,000-9,000 jobs from its workforce of 55,000 over the next three years, which the company says ultimately will save $1B/year.</li><li>But in the short term, the restructuring will <a href=\"https://www.wsj.com/articles/hp-to-cut-up-to-9-000-jobs-in-new-ceos-restructuring-plan-11570143485\" target=\"_blank\">weigh on HP's bottom line</a>: The company forecasts FY 2020 GAAP earnings per share of $1.98-$2.10, well below the $2.18 analyst consensus estimate.</li><li>On an adjusted basis, which would strip out the restructuring costs and other items, HP guides FY 2020 EPS of $2.22-$2.32, compared with $2.24 analyst consensus.</li><li>HPQ <font color=\"red\">-2.5%</font> after-hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503912\" data-linked=\"HP to cut up to 9K jobs in restructuring; guides 2020 EPS below consensus\" data-tweet=\"$HPQ - HP to cut up to 9K jobs in restructuring; guides 2020 EPS below consensus https://seekingalpha.com/news/3503912-hp-to-cut-up-to-9k-jobs-in-restructuring-guides-2020-eps-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3503912-hp-to-cut-up-to-9k-jobs-in-restructuring-guides-2020-eps-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503901\" data-ts=\"1570140123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABUS\" target=\"_blank\">ABUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503901-arbutusminus-24_5-discontinues-hepatitis-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arbutus -24.5% as it discontinues hepatitis treatment</a></h4><ul>   <li>Arbutus Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corporation'>ABUS</a>) has tanked after hours, <font color=\"red\">falling 24.5%</font> after a decision to <a href=\"https://seekingalpha.com/pr/17653281-arbutus-announces-decision-discontinue-development-abminus-506-oral-capsid-inhibitor\" target=\"_blank\">stop development of AB-506</a>.</li>    <li>That is an oral capsid inhibitor for the treatment of chronic hepatitis B.</li>    <li>\u201cWe have observed two cases of acute hepatitis in our Phase 1a 28-day clinical trial in healthy volunteers,\" says CEO William Collier. \"Consequently, the clinical trial and further development of AB-506 have been stopped.\u201d</li>    <li>The two subjects are experiencing resolution of the acute hepatitis, he adds.</li>    <li>\u201cWhile we are disappointed in these recent clinical findings, we have a number of oral follow-on capsid inhibitor compounds with distinct chemical scaffolds that we believe have the potential to contribute to the inhibition of HBV replication as part of a combination regimen,\" says Chief Scientific Officer Michael Sofia. \"Our objective is to select one of several lead compounds for IND-enabling studies by December of this year.\u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503901\" data-linked=\"Arbutus -24.5% as it discontinues hepatitis treatment\" data-tweet=\"$ABUS - Arbutus -24.5% as it discontinues hepatitis treatment https://seekingalpha.com/news/3503901-arbutusminus-24_5-discontinues-hepatitis-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3503901-arbutusminus-24_5-discontinues-hepatitis-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503899\" data-ts=\"1570139329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503899-rng-ovid-wll-and-avya-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RNG, OVID, WLL and AVYA among notable after hours movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a> <font color=\"green\">+18.6%</font>. <a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a> <font color=\"green\">+8.6%. </font><a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a> <font color=\"green\">+8.6%</font>. <a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Company'>CPE</a> <font color=\"green\">+2.5%</font>. <a href='https://seekingalpha.com/symbol/VIAV' title='Viavi Solutions Inc.'>VIAV</a> <font color=\"green\">+2.5%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a> <font color=\"red\">-13.7%</font>. <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a> <font color=\"red\">-9.5%</font>. <a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a> <font color=\"red\">-2.6%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color=\"red\">-2.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503899\" data-linked=\"RNG, OVID, WLL and AVYA among notable after hours movers\" data-tweet=\"$AVYA $CMRX $RNG - RNG, OVID, WLL and AVYA among notable after hours movers https://seekingalpha.com/news/3503899-rng-ovid-wll-and-avya-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503899-rng-ovid-wll-and-avya-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503881\" data-ts=\"1570134899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503881-avayaplus-11-on-ringcentral-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avaya +11% on RingCentral partnership</a></h4><ul><li>Avaya (NYSE:<a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a>) <font color=\"green\">+11.2%</font> <a href=\"https://seekingalpha.com/pr/17653285-avaya-announces-strategic-partnership-ringcentral-accelerate-transformation-cloud\" target=\"_blank\">announces</a> a strategic partnership with RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) <font color=\"green\">+5.8%</font>, which will include the launch of Cloud Office by RingCentral, a global unified communications as a service solution.</li><li>RingCentral will contribute $500M to the partnership with Avaya and pay an advance of $375M primarily in stock for future payments and licensing rights.</li><li>AVYA's board also announces a new $500M share repurchase program and plans to pay down $250M of its principal debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503881\" data-linked=\"Avaya +11% on RingCentral partnership\" data-tweet=\"$AVYA $RNG - Avaya +11% on RingCentral partnership https://seekingalpha.com/news/3503881-avayaplus-11-on-ringcentral-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3503881-avayaplus-11-on-ringcentral-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503880\" data-ts=\"1570134714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEIP\" target=\"_blank\">MEIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503880-mei-pharmaplus-16_7-on-updated-early-stage-trial-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MEI Pharma +16.7% on updated early-stage trial data</a></h4><ul>   <li>MEI Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a>) has <font color=\"green\">risen another 16.7%</font> postmarket after citing <a href=\"https://seekingalpha.com/pr/17653269-mei-pharma-announces-updated-clinical-dataminus-401-phase-1b-study-patients-indolent-b-cell\" target=\"_blank\">updated clinical data</a> from an early-stage trial.</li>    <li>The company announced data from an ongoing Phase 1b study of investigational ME-401 in patients with indolent B-cell malignancies.</li>    <li>It will present the data at the company's investor and analyst event, starting tomorrow at 8 a.m. ET.</li>    <li>The company will also review progress across the pipeline of its four clinical-stage oncology candidates, with a focus on voruciclib, a cyclin-dependent kinase inhibitor with potent CDK9 inhibition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503880\" data-linked=\"MEI Pharma +16.7% on updated early-stage trial data\" data-tweet=\"$MEIP - MEI Pharma +16.7% on updated early-stage trial data https://seekingalpha.com/news/3503880-mei-pharmaplus-16_7-on-updated-early-stage-trial-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3503880-mei-pharmaplus-16_7-on-updated-early-stage-trial-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503876\" data-ts=\"1570134456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503876-j-and-js-janssen-gets-breakthrough-designation-for-niraparib-in-prostate-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J&#39;s Janssen gets breakthrough designation for niraparib in prostate cancer</a></h4><ul><li>The U.S. Food and Drug Administrations<a href=\"https://seekingalpha.com/pr/17653322-janssen-announces-u-s-fda-breakthrough-therapy-designation-granted-niraparib-treatment\" target=\"_blank\"> grants</a> Johnson &amp; Johnson's (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) Janssen Pharmaceutical unit a breakthrough therapy designation for niraparib, an orally administered PARP inhibitor for the treatment of patients with a certain type of prostate cancer and who have already been treated with taxane chemotherapy and androgen receptor-targeted therapy.</li><li>JNJ <font color=\"green\">gains 1.0%</font> in after-hours trading.</li><li>The poly ADP-ribose polymerase inhibitor is being studied to treat patients with BRCA1/2 gene-mutated metastatic castration-resistant prostate cancer. BRCA1/2 mutations are the most common DNA-repair gene defects &#40;DRD&#41; in patients with mCRPC.</li><li>The designation is based on data from the Galahad study, a Phase 2, multicenter, open-label clinical trial evaluating the efficacy and safety of niraparib in the treatment of adult patients with mCRPC and DRD who had received treatment with next-generation androgen-receptor targeting therapies and docetaxel.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503876\" data-linked=\"J&amp;J&#39;s Janssen gets breakthrough designation for niraparib in prostate cancer\" data-tweet=\"$JNJ - J&amp;J&#39;s Janssen gets breakthrough designation for niraparib in prostate cancer https://seekingalpha.com/news/3503876-j-and-js-janssen-gets-breakthrough-designation-for-niraparib-in-prostate-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3503876-j-and-js-janssen-gets-breakthrough-designation-for-niraparib-in-prostate-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503875\" data-ts=\"1570134271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503875-heron-therapeuticsminus-4_5-on-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics -4.5% on share offering</a></h4><ul>   <li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) is <font color=\"red\">4.5% lower</font> after hours following its announcement of a proposed <a href=\"https://seekingalpha.com/pr/17653259-heron-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering of common stock</a>.</li>    <li>Joint book-runners are Jefferies, Cowen and Evercore ISI. Heron intends to grant underwriters a 30-day option to buy up to an additional 15% of shares.</li>    <li>Proceeds will go toward the commercial launch of HTX-011 (if approved), commercialization and marketing of Sustol and Cinvanti, ongoing and future clinical trials, preclinical development, other development activities and general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503875\" data-linked=\"Heron Therapeutics -4.5% on share offering\" data-tweet=\"$HRTX - Heron Therapeutics -4.5% on share offering https://seekingalpha.com/news/3503875-heron-therapeuticsminus-4_5-on-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3503875-heron-therapeuticsminus-4_5-on-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503874\" data-ts=\"1570134063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503874-costco-reports-5-comparable-sales-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco reports 5% comparable sales increase</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) falls slightly after reporting <a href=\"https://seekingalpha.com/pr/17653302-costco-wholesale-corporation-reports-fourth-quarter-fiscal-year-2019-operating-results\" target=\"_blank\">FQ4</a> membership fees were up 5.3% Y/Y to $1.05B to match expectations.</li>  <li>During the quarter, comparable sales rose 5.2% in the U.S. on an adjusted basis, 4.7% in Canada and 5.0% in international markets. E-commerce sales were up 21.9%.</li> <li>Net income  was $1.097B vs. $1.043B a year ago.</li> <li>Costco has an <a href=\"http://investor.costco.com/investor-overview\" target=\"_blank\">earnings call</a> scheduled for 5:00 p.m. EST.</li> <li>Shares of COST are <font color=\"red\">down 2.29%</font> in AH trading to $282.37 vs. a 52-week trading range of $189.51 to $307.34.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503874\" data-linked=\"Costco reports 5% comparable sales increase\" data-tweet=\"$COST - Costco reports 5% comparable sales increase https://seekingalpha.com/news/3503874-costco-reports-5-comparable-sales-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3503874-costco-reports-5-comparable-sales-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503869\" data-ts=\"1570133929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OVID\" target=\"_blank\">OVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503869-ovidminus-13-on-common-preferred-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ovid -13% on common, preferred offerings</a></h4><ul>    <li>Ovid Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a>) has <font color=\"red\">tumbled 13.1%</font> postmarket after announcing <a href=\"https://seekingalpha.com/pr/17653258-ovid-therapeutics-announces-proposed-concurrent-public-offerings-common-stock-preferred-stock\" target=\"_blank\">public offerings</a> of common stock and preferred stock.</li>    <li>Those will come via concurrent, separate offerings.</li>    <li>Joint book-runners are Cowen and William Blair. Underwriters will get a 30-day greenshoe option to buy up to 15% more shares to cover overallotment.</li>    <li>Proceeds will go primarily to advance clinical development of OV101 and OV935, along with general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503869\" data-linked=\"Ovid -13% on common, preferred offerings\" data-tweet=\"$OVID - Ovid -13% on common, preferred offerings https://seekingalpha.com/news/3503869-ovidminus-13-on-common-preferred-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3503869-ovidminus-13-on-common-preferred-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503867\" data-ts=\"1570133829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503867-smart-globalminus-17-on-misses-downside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smart Global -17% on misses, downside guide</a></h4><ul><li>Smart Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) <font color=\"red\">-17.3%</font> <a href=\"https://seekingalpha.com/news/3503854-smart-global-eps-misses-0_17-misses-revenue\" target=\"_blank\">reports Q4 misses</a> with revenue down 26% Y/Y. Management blames the miss on weakness in the supply chain services business.</li><li>Downside Q1 guidance sees revenue of $275-285M (consensus: $309.33M) and EPS of $0.68-0.78 (consensus: $0.85).</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"https://www.globenewswire.com/Tracker?data=HCzXaqyOJbkgCP4r2YCU_k9wbJReRj-v4Kf6AifbgHVT26K5JLj0Q4pchn8DZRJzJQn18Tywm5eXbJ4HE4sPZQ==\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17653283-smart-global-holdings-reports-fourth-quarter-full-year-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503867\" data-linked=\"Smart Global -17% on misses, downside guide\" data-tweet=\"$SGH - Smart Global -17% on misses, downside guide https://seekingalpha.com/news/3503867-smart-globalminus-17-on-misses-downside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3503867-smart-globalminus-17-on-misses-downside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503860\" data-ts=\"1570133272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503860-ascena-retailminus-8-after-margins-crumble-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascena Retail -8% after margins crumble again</a></h4><ul> <li>Ascena Retail Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group, Inc.'>ASNA</a>) reports comparable sales were flat in <a href=\"https://seekingalpha.com/pr/17653270-ascena-retail-group-inc-announces-fourth-quarter-fiscal-2019-results-exceeds-guidance-sales\" target=\"_blank\">FQ4</a>.</li> <li>Comparable sales gains at Dressbarn (+12%) and Total Premium Fashion (+1%) were offset by drops at Justice (-5%), Catherines (-8%) and Lane Bryant (-3%).</li>  <li>Gross margin fell 320 bps to 54.3% of sales. The decline in gross margin rate was primarily due to higher promotional activity to address elevated inventory levels.</li>  <li>Looking ahead, Ascena sees FQ1 sales of $1.10B to $1.13B.</li>  <li>Shares of ASNA are <font color=\"red\">down 8.32% </font>AH to $0.27.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503860\" data-linked=\"Ascena Retail -8% after margins crumble again\" data-tweet=\"$ASNA - Ascena Retail -8% after margins crumble again https://seekingalpha.com/news/3503860-ascena-retailminus-8-after-margins-crumble-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3503860-ascena-retailminus-8-after-margins-crumble-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503846\" data-ts=\"1570132823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTX\" target=\"_blank\">MKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503846-marketaxess-rises-since-june-on-strong-september-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MarketAxess rises most since June on strong September volume</a></h4><ul><li>MarketAxess (NASDAQ:<a href='https://seekingalpha.com/symbol/MKTX' title='MarketAxess Holdings Inc.'>MKTX</a>) <font color=\"green\">jumps 5.8%</font>, its biggest gain since June 5 after September volume exceeded analysts estimates.</li><li>Total <a href=\"https://seekingalpha.com/pr/17651733-marketaxess-announces-monthly-volume-statistics-september-2019\" target=\"_blank\">monthly trading volume</a> of $176.1B consisted of $88.7B in U.S. high-grade volume, $83.9B in other credit volume, and $3.5B in liquid products volume.</li><li>Preliminary total variable transaction fees per million &#40;FPM&#41; were $182 for the quarter ended Sept. 30, 2019.</li><li>MarketAxess's total Q3 average daily volume topped KBW's estimate by 8%, wrote analyst Kyle Voigt.</li><li>Chris Allen, analyst at Compass Point, increased his estimates for Q3, 2019, and 2020 to reflect \"recent volume strength and much better than expected FPM trends.\"</li><li>via Blooomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503846\" data-linked=\"MarketAxess rises most since June on strong September volume\" data-tweet=\"$MKTX - MarketAxess rises most since June on strong September volume https://seekingalpha.com/news/3503846-marketaxess-rises-since-june-on-strong-september-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3503846-marketaxess-rises-since-june-on-strong-september-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503847\" data-ts=\"1570132772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503847-amicus-snaps-back-on-positive-data-from-gaa-pompe-disease-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus snaps back on positive data from AT-GAA Pompe disease study</a></h4><ul><li>Amicus Therapeutics (<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a> <font color=\"green\">+6.5%</font>) rebounds on heavy volume a day after dropping to fresh two-year lows before ultimately netting a gain for the day.</li><li>FOLD yesterday reported <a href=\"https://seekingalpha.com/pr/17650650-amicus-therapeutics-announces-additional-positive-data-pompe-disease-phase-1-2-study-gaa-24th\" target=\"_blank\">additional \"positive\" results</a> from a Phase 1/2 clinical study investigating AT-GAA in adult patients with Pompe disease; the Food and Drug Administration previously granted  Breakthrough Therapy Designation to AT-GAA for the treatment of  late onset Pompe disease based on clinical efficacy results the study.</li><li>The company says it will present the results tomorrow at the International Annual Congress of the World Muscle Society.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503847\" data-linked=\"Amicus snaps back on positive data from AT-GAA Pompe disease study\" data-tweet=\"$FOLD - Amicus snaps back on positive data from AT-GAA Pompe disease study https://seekingalpha.com/news/3503847-amicus-snaps-back-on-positive-data-from-gaa-pompe-disease-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3503847-amicus-snaps-back-on-positive-data-from-gaa-pompe-disease-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503839\" data-ts=\"1570130903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503839-catalyst-pharma-stops-dip-after-ceo-share-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma stops dip after CEO share purchase</a></h4><ul>   <li>Catalyst Pharmaceuticals (<a href=\"http://seekingalpha.com/symbol/CPRX\" target=\"_blank\">CPRX</a> <font color=\"red\">-3.1%</font>) is trimming losses after the disclosure of an insider purchase from its CEO and president.</li>    <li>Patrick McEnany bought 10,000 shares today, according to a <a href=\"https://seekingalpha.com/filing/4656375\" target=\"_blank\">filing</a> just posted.</li>    <li>The purchase came at a price of $4.89.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503839\" data-linked=\"Catalyst Pharma stops dip after CEO share purchase\" data-tweet=\"$CPRX - Catalyst Pharma stops dip after CEO share purchase https://seekingalpha.com/news/3503839-catalyst-pharma-stops-dip-after-ceo-share-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3503839-catalyst-pharma-stops-dip-after-ceo-share-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503838\" data-ts=\"1570130136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503838-finjanplus-8_5-on-mimecast-patent-truce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan +8.5% on Mimecast patent truce</a></h4><ul><li>Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) and its subsidiaries each enter into a <a href=\"https://seekingalpha.com/pr/17653198-finjan-mimecast-enter-confidential-agreements-achieve-global-patent-peace-companies\" target=\"_blank\">patent license agreement</a> with Mimecast (NASDAQ:<a href='https://seekingalpha.com/symbol/MIME' title='Mimecast Limited'>MIME</a>) and enter into mutual covenants not to sue for a certain number of years, among other confidential terms.</li><li>Finjan shares are <font color=\"green\">up 8.5%</font>. Mimecast shares are <font color=\"green\">up 2.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503838\" data-linked=\"Finjan +8.5% on Mimecast patent truce\" data-tweet=\"$FNJN $MIME - Finjan +8.5% on Mimecast patent truce https://seekingalpha.com/news/3503838-finjanplus-8_5-on-mimecast-patent-truce?source=tweet\" data-url=\"https://seekingalpha.com/news/3503838-finjanplus-8_5-on-mimecast-patent-truce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503837\" data-ts=\"1570129814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBIO\" target=\"_blank\">CBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503837-catalyst-bio-reports-positive-trial-update-on-blood-disorder-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Bio reports positive trial update on blood disorder drug</a></h4><ul><li>Catalyst Biosciences (<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+20%</font>) spikes higher following a <a href=\"https://seekingalpha.com/pr/17652323-catalyst-biosciences-provides-dalca-phase-2b-trial-update\" target=\"_blank\">positive update</a> on its Phase 2 study of dalcinonacog alfa ((DalcA)), a next-generation subcutaneously administered Factor IX therapy being developed for the treatment of hemophilia B.</li><li>CBIO says two subjects have completed dosing and washout, and Factor IX levels in the subjects exceeded the trial efficacy endpoint of greater than 12% activity and no anti-drug antibodies were detected.</li><li>The trial is expected to enroll up to six completing subjects who will  receive a single intravenous dose, followed by daily subcutaneous doses of DalcA for 28 days; CBIO expects to report final data in H1 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503837\" data-linked=\"Catalyst Bio reports positive trial update on blood disorder drug\" data-tweet=\"$CBIO - Catalyst Bio reports positive trial update on blood disorder drug https://seekingalpha.com/news/3503837-catalyst-bio-reports-positive-trial-update-on-blood-disorder-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3503837-catalyst-bio-reports-positive-trial-update-on-blood-disorder-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503832\" data-ts=\"1570128997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503832-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><strong>Gainers:</strong> The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <font color=\"green\">+24%</font>. TuanChe (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"green\">+13%</font>. Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) <font color=\"green\">+11%</font>. CrowdStrike Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) <font color=\"green\">+9%</font>. LINE (NYSE:<a href='https://seekingalpha.com/symbol/LN' title='LINE Corporation'>LN</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers:</strong> AXT (NASDAQ:<a href='https://seekingalpha.com/symbol/AXTI' title='AXT, Inc.'>AXTI</a>) <font color=\"red\">-16%</font>. Marin Software (NASDAQ:<a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software Incorporated'>MRIN</a>) <font color=\"red\">-9%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"red\">-8%</font>. MoSys (NASDAQ:<a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a>) <font color=\"red\">-6%</font>. One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503832\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$MEET $TC $OKTA - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3503832-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503832-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503831\" data-ts=\"1570128477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXAS\" target=\"_blank\">AXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503831-abraxas-suspends-delaware-basin-drilling-sells-7_9m-of-texas-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abraxas suspends Delaware Basin drilling, sells $7.9M of Texas assets</a></h4><ul><li>Abraxas Petroleum (<a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a> <font color=\"green\">+3.5%</font>) says it has <a href=\"https://seekingalpha.com/pr/17653059-abraxas-announces-agreements-sell-non-core-assets-provides-operational-update-provides-third\" target=\"_blank\">suspended drilling</a> operations in the Delaware Basin, and plans to drill three commitment wells - two of them 100% owned by AXAS - in 2020.</li><li>In an operations update, AXAS also says its 100%-owned two-well Woodberry Pad in Ward County, Tex., has produced 72K barrels of oil and 85M cf of gas over the first 66 days of production.</li><li>Also in Ward County, AXAS says frac jobs on its 100%-owned two-well Greasewood NE pad should be completed in the next several days with flowback to begin shortly thereafter.</li><li>Finally, AXAS agrees to sell two non-core assets for $7.9M; one sale represents all of the company\u2019s remaining south Texas assets, and the other is a non-operated acreage position in Reeves County, Tex.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503831\" data-linked=\"Abraxas suspends Delaware Basin drilling, sells $7.9M of Texas assets\" data-tweet=\"$AXAS - Abraxas suspends Delaware Basin drilling, sells $7.9M of Texas assets https://seekingalpha.com/news/3503831-abraxas-suspends-delaware-basin-drilling-sells-7_9m-of-texas-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3503831-abraxas-suspends-delaware-basin-drilling-sells-7_9m-of-texas-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503825\" data-ts=\"1570126868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503825-paypal-closer-to-quitting-facebooks-libra-ft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal closer to quitting Facebook&#39;s Libra - FT</a></h4><ul>   <li>PayPal (<a href=\"http://seekingalpha.com/symbol/PYPL\" target=\"_blank\">PYPL</a> <font color=\"green\">+1.2%</font>) is \"on the verge\" of <a href=\"https://www.ft.com/content/6af11092-e5fd-11e9-9743-db5a370481bc\" target=\"_blank\">exiting</a> Facebook's (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+2.7%</font>) Libra payments project, the <i>Financial Times</i> reports.</li>    <li>That comes as the payments giant pulled out of a key meeting called by the Libra Association for today in Washington, D.C. -- a precursor to a scheduled Oct. 14 meeting in Geneva.</li><li>Facebook hasn't yet done enough to assuage PayPal's worries about a backlash, particularly concerns over money laundering, according to the report.</li>    <li>Today's meeting was set against the backdrop of <a href=\"https://seekingalpha.com/news/3503203-facebook-scrambles-libra-partners-reconsider-wsj\" target=\"_blank\">cracks forming in the Libra coalition</a>, with reports that Visa, Mastercard and other partners were thinking of quitting the project amid increasing regulatory pressure at home and abroad.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3503825\" data-linked=\"PayPal closer to quitting Facebook&#39;s Libra - FT\" data-tweet=\"$PYPL $FB - PayPal closer to quitting Facebook&#39;s Libra - FT https://seekingalpha.com/news/3503825-paypal-closer-to-quitting-facebooks-libra-ft?source=tweet\" data-url=\"https://seekingalpha.com/news/3503825-paypal-closer-to-quitting-facebooks-libra-ft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503823\" data-ts=\"1570126654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503823-slackplus-6-on-positive-cnbc-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack +6% on positive CNBC mention</a></h4><ul><li>Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) gains after CNBC contributor Josh Brown <a href=\"https://www.cnbc.com/video/2019/10/03/trader-double-downs-on-slack.html\" target=\"_blank\">says </a>he sees the company as a \"category killer.\"</li><li>Brown says he doubled his position when shares dropped into the low $20s and wants to stay in the stock for three to five years.</li><li>Slack shares are currently <font color=\"green\">up 5.7%</font> to $24.76.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503823\" data-linked=\"Slack +6% on positive CNBC mention\" data-tweet=\"$WORK - Slack +6% on positive CNBC mention https://seekingalpha.com/news/3503823-slackplus-6-on-positive-cnbc-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3503823-slackplus-6-on-positive-cnbc-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503822\" data-ts=\"1570126080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503822-stabilis-energy-and-synthesis-energy-systems-among-energy-materials-gainers-contango-oil-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stabilis Energy and Synthesis Energy Systems among Energy/Materials gainers; Contango Oil &amp; Gas and Yuma Energy among losers</a></h4><ul><li><b>Gainers: </b>Stabilis Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SLNG' title='Stabilis Energy, Inc.'>SLNG</a>) <font color=\"green\">+19%</font>. Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"green\">+18%</font>. Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a>) <font color=\"green\">+9%</font>. Tellurian (NASDAQ:<a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a>) <font color=\"green\">+6%</font>. Range Resources (NYSE:<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"red\">-9%</font>. Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-9%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"red\">-7%</font>. Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia Limited'>SNDE</a>) <font color=\"red\">-7%</font>. Platinum Group Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd.'>PLG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503822\" data-linked=\"Stabilis Energy and Synthesis Energy Systems among Energy/Materials gainers; Contango Oil &amp; Gas and Yuma Energy among losers\" data-tweet=\"$SLNG $SES $CLF - Stabilis Energy and Synthesis Energy Systems among Energy/Materials gainers; Contango Oil &amp; Gas and Yuma Energy among losers https://seekingalpha.com/news/3503822-stabilis-energy-and-synthesis-energy-systems-among-energy-materials-gainers-contango-oil-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/3503822-stabilis-energy-and-synthesis-energy-systems-among-energy-materials-gainers-contango-oil-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503820\" data-ts=\"1570125546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503820-analysts-defend-gopro-after-camera-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts defend GoPro after camera delay</a></h4><ul><li>Morgan Stanley expects GoPro (<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a> <font color='red'>-19.8%</font>) to \"recoup some of this lost demand in early 2020.\"</li><li>The firm says the <a href=\"https://seekingalpha.com/news/3503618-gopro-minus-14-percent-trims-2019-guidance\" target=\"_blank\">HERO8 Black delay</a> will will create a significant headwind for Q3 results, but a tailwind for Q4.</li><li>Morgan maintains an Underweight rating and lowers the PT from $5 to $4.50.</li><li>Citi says \"investors will view the production delay as a negative which will partly overshadow some of positive shine of the new products launched.\" Analyst Jim Suva says the delay should be resolved within weeks with no effect on Christmas shopping and no material change to Citi's longer-term model.</li><li>Citi maintains a Neutral rating and $4.50 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503820\" data-linked=\"Analysts defend GoPro after camera delay\" data-tweet=\"$GPRO - Analysts defend GoPro after camera delay https://seekingalpha.com/news/3503820-analysts-defend-gopro-after-camera-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3503820-analysts-defend-gopro-after-camera-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503818\" data-ts=\"1570125107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503818-firearm-background-checks-up-sharply-in-september\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearm background checks up sharply in September</a></h4><ul>  <li>Firearm background checks rose 10.0% in September to 1,011,636 on an adjusted basis compared to a year ago, according to NICS data. Background checks were up 12.8% to 2,207,312 on an unadjusted basis.</li> <li>Handguns checks were up 11.9% on an adjusted basis and long guns checks were 7.5% higher.</li> <li>Related stocks: American Outdoor Brands  (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='red'>-2.8%</font>), Sturm, Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company, Inc.'>RGR</a> <font color='green'>+0.7%</font>), Vista Outdoor (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor Inc.'>VSTO</a> <font color='red'>-2.6%</font>) and Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-1%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3503818\" data-linked=\"Firearm background checks up sharply in September\" data-tweet=\"$AOBC $RGR $VSTO - Firearm background checks up sharply in September https://seekingalpha.com/news/3503818-firearm-background-checks-up-sharply-in-september?source=tweet\" data-url=\"https://seekingalpha.com/news/3503818-firearm-background-checks-up-sharply-in-september\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503814\" data-ts=\"1570123890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503814-accounting-rule-change-latest-headwind-for-harley-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accounting rule change the latest headwind for Harley-Davidson</a></h4><ul> <li>Wedbush <a href=\"https://www.barrons.com/articles/accounting-rule-trump-big-bikes-harley-davidson-51570120278\" target=\"_blank\">warns</a> that Harley-Davidson (<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a>) faces a speed bump with some new accounting rules.</li> <li>The FASB's Current Expected Credit Losses accounting model for credit losses goes into effect in December in a development that Wedbush says could \"ratchet up\" volatility for Harley-Davidson Financial services. A $120M non-cash write-down by Harley is expected.</li> <li>Harley, which is still facing tariff headwinds and pressure from President Trump on manufacturing, is down 20% over the last 52 weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503814\" data-linked=\"Accounting rule change the latest headwind for Harley-Davidson\" data-tweet=\"$HOG - Accounting rule change the latest headwind for Harley-Davidson https://seekingalpha.com/news/3503814-accounting-rule-change-latest-headwind-for-harley-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/3503814-accounting-rule-change-latest-headwind-for-harley-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503813\" data-ts=\"1570123786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCO\" target=\"_blank\">TCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503813-taubmanminus-1_9-sandler-oneill-steps-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taubman -1.9% as Sandler O&#39;Neill steps to sidelines</a></h4><ul><li>Taubman Centers (NYSE:<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a>)<font color=\"red\"> sinks 1.9%</font> after Sandler O'Neill analyst Alexander D. Goldfarb downgrades the stock to hold from buy.</li><li>Price target cut to $41 from $50; compares with average price target of $48.00.</li><li>Even before this action, the Sell-Side average rating was<a href=\"https://seekingalpha.com/symbol/TCO/ratings/sell-side-ratings\" target=\"_blank\"> Hold </a>(2 Buy, 1 Outperform, 13 Hold).</li><li>Compare <a href=\"https://seekingalpha.com/symbol/TCO/peers/comparison\" target=\"_blank\">Taubman's key stats </a>with those of its peers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503813\" data-linked=\"Taubman -1.9% as Sandler O&#39;Neill steps to sidelines\" data-tweet=\"$TCO - Taubman -1.9% as Sandler O&#39;Neill steps to sidelines https://seekingalpha.com/news/3503813-taubmanminus-1_9-sandler-oneill-steps-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3503813-taubmanminus-1_9-sandler-oneill-steps-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503909\" data-ts=\"1570122928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTMDF\" target=\"_blank\">FTMDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503909-fortune-minerals-trims-plans-for-canadian-cobalt-mine-on-weak-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortune Minerals trims plans for Canadian cobalt mine on weak prices</a></h4><ul><li>Fortune Minerals (<a href='https://seekingalpha.com/symbol/FTMDF' title='Fortune Minerals Limited'>OTCQB:FTMDF</a> <font color='red'>-8.9%</font>) says it will <a href=\"https://www.reuters.com/article/us-fortune-minerals-cobalt/canadas-fortune-minerals-scales-back-mine-on-weak-cobalt-prices-idUSKBN1WI1QZ\" target=\"_blank\">scale back plans</a> to upsize  its proposed Nico cobalt mine in Canada's Northwest Territories, as cobalt prices have slumped from $47K/mt to ~$35,470/mt.</li><li>Fortune said current prices do not justify expanding the daily mill production rate to 6K metric tons from 4,650 mt at the proposed project.</li><li>Weak cobalt prices recently caused Glencore to halt production for two years at its giant Mutanda copper and  cobalt mine in the Democratic Republic of Congo.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503909\" data-linked=\"Fortune Minerals trims plans for Canadian cobalt mine on weak prices\" data-tweet=\"$FTMDF - Fortune Minerals trims plans for Canadian cobalt mine on weak prices https://seekingalpha.com/news/3503909-fortune-minerals-trims-plans-for-canadian-cobalt-mine-on-weak-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3503909-fortune-minerals-trims-plans-for-canadian-cobalt-mine-on-weak-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503808\" data-ts=\"1570122744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503808-box-announces-adobe-splunk-integrations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box announces Adobe, Splunk integrations</a></h4><ul><li>Box (<a href='https://seekingalpha.com/symbol/BOX' title='Box, Inc.'>BOX</a> <font color='red'>-0.8%</font>) and Adobe (<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Inc.'>ADBE</a> <font color='green'>+2.1%</font>) <a href=\"https://seekingalpha.com/pr/17653022-box-adobe-streamline-seamless-secure-collaboration-cloud\" target=\"_blank\">announce </a>an integration that brings to Box a \"full-featured Acrobat web experience\" including PDF editing and management. The integrations will become available next year.</li><li>Splunk (<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a> <font color='green'>+1.9%</font>) will build a new integration with Box Shield, the set of content security controls and intelligent threat detection. Users can better monitor Box Shield alerts with the Splunk app, and security teams using Splunk Phantom can automate responses in Box.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503808\" data-linked=\"Box announces Adobe, Splunk integrations\" data-tweet=\"$BOX $ADBE $SPLK - Box announces Adobe, Splunk integrations https://seekingalpha.com/news/3503808-box-announces-adobe-splunk-integrations?source=tweet\" data-url=\"https://seekingalpha.com/news/3503808-box-announces-adobe-splunk-integrations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503806\" data-ts=\"1570122281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503806-calamp-discloses-verdict-infringed-omega-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp discloses verdict that it infringed Omega patents</a></h4><ul>   <li>CalAmp (<a href=\"http://seekingalpha.com/symbol/CAMP\" target=\"_blank\">CAMP</a> <font color=\"red\">-4.2%</font>) has disclosed in a <a href=\"https://seekingalpha.com/filing/4655741\" target=\"_blank\">filing</a> that a jury found it infringed two of four patents in a case against Omega Patents.</li>    <li>That jury awarded damages of $4.6M in the case. It was an appeal of a previous award of $15M on a decision that all four patents on vehicle tracking products were infringed (a decision that was vacated and sent for new trial).</li>    <li>It found no willful infringement, the filing notes, and on one patent the jury found just one unit infringed and assessed $1 in damages. On a second patent, the jury found direct infringement and awarded damages at $5/unit, summing to the $4.6M.</li>    <li>CalAmp says it disagrees with this verdict and may pursue another appeal as needed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503806\" data-linked=\"CalAmp discloses verdict that it infringed Omega patents\" data-tweet=\"$CAMP - CalAmp discloses verdict that it infringed Omega patents https://seekingalpha.com/news/3503806-calamp-discloses-verdict-infringed-omega-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3503806-calamp-discloses-verdict-infringed-omega-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503804\" data-ts=\"1570122111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503804-clearsign-combustion-and-euro-tech-holdings-in-industrial-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClearSign Combustion and Euro Tech Holdings in industrial gainers</a></h4><ul><li><b>Gainers: </b>ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"green\">+10%</font>. Euro Tech Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3503804\" data-linked=\"ClearSign Combustion and Euro Tech Holdings in industrial gainers\" data-tweet=\"$CLIR $CLWT - ClearSign Combustion and Euro Tech Holdings in industrial gainers https://seekingalpha.com/news/3503804-clearsign-combustion-and-euro-tech-holdings-in-industrial-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503804-clearsign-combustion-and-euro-tech-holdings-in-industrial-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503802\" data-ts=\"1570121711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503802-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers:</strong> PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+23%</font>. The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <font color=\"green\">+20%</font>. Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"green\">+14%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc.'>MBOT</a>) <font color=\"green\">+19%</font>. TuanChe (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"green\">+14%</font>. Arcturus Therapeutics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Holdings Inc.'>ARCT</a>) <font color=\"green\">+14%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+11%</font>. Stabilis Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SLNG' title='Stabilis Energy, Inc.'>SLNG</a>) <font color=\"green\">+11%</font>. Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) <font color=\"green\">+10%</font>. Summit Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers:</strong> Enlivex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ENLV' title='Enlivex Therapeutics Ltd.'>ENLV</a>) <font color=\"red\">-36%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-25%</font>. GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <font color=\"red\">-19%</font>. AXT (NASDAQ:<a href='https://seekingalpha.com/symbol/AXTI' title='AXT, Inc.'>AXTI</a>) <font color=\"red\">-18%</font>. AngioDynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a>) <font color=\"red\">-17%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-16%</font>. TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"red\">-15%</font>. Resources Connection (NASDAQ:<a href='https://seekingalpha.com/symbol/RECN' title='Resources Connection, Inc.'>RECN</a>) <font color=\"red\">-13%</font>. NanoViricides (NYSEMKT:<a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a>) <font color=\"red\">-11%</font>. Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503802\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$PDSB $MEET $SES - Microcaps mostly among midday movers https://seekingalpha.com/news/3503802-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503802-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503800\" data-ts=\"1570121420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503800-ashford-and-marketaxess-holdings-among-financial-gainers-conifer-holdings-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ashford and MarketAxess Holdings among financial gainers, Conifer Holdings leads losers</a></h4><ul><li><b>Gainers:</b> MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+8%</font>. Ashford (NYSEMKT:<a href='https://seekingalpha.com/symbol/AINC' title='Ashford Inc.'>AINC</a>) <font color=\"green\">+6%</font>. Essential Properties Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/EPRT' title='Essential Properties Realty Trust, Inc.'>EPRT</a>) <font color=\"green\">+5%</font>. MarketAxess Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MKTX' title='MarketAxess Holdings Inc.'>MKTX</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Conifer Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNFR' title='Conifer Holdings, Inc.'>CNFR</a>) <font color=\"red\">-7%</font>. BBX Capital (NYSE:<a href='https://seekingalpha.com/symbol/BBX' title='BBX Capital Corporation'>BBX</a>) <font color=\"red\">-6%</font>. Atlanticus Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corporation'>ATLC</a>) <font color=\"red\">-6%</font>. AMTD International (NYSE:<a href='https://seekingalpha.com/symbol/HKIB' title='AMTD International Inc.'>HKIB</a>) <font color=\"red\">-6%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yiren Digital Ltd.'>YRD</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503800\" data-linked=\"Ashford and MarketAxess Holdings among financial gainers, Conifer Holdings leads losers\" data-tweet=\"$MGI $AINC $EPRT - Ashford and MarketAxess Holdings among financial gainers, Conifer Holdings leads losers https://seekingalpha.com/news/3503800-ashford-and-marketaxess-holdings-among-financial-gainers-conifer-holdings-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503800-ashford-and-marketaxess-holdings-among-financial-gainers-conifer-holdings-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503799\" data-ts=\"1570121418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVLT\" target=\"_blank\">CVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503799-commvaultplus-2_6-on-raised-q2-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commvault +2.6% on raised Q2 view</a></h4><ul><li>Commvault (NASDAQ:<a href='https://seekingalpha.com/symbol/CVLT' title='Commvault Systems, Inc.'>CVLT</a>) <a href=\"https://seekingalpha.com/pr/17652447-commvault-launches-global-enterprise-segment-names-anthony-faustini-vice-president-former-emc\" target=\"_blank\">now expects</a> its Q2 results to exceed the previously provided guidance that included relatively flat revenue Q/Q, or about $162-163M.</li><li>CVLT will report Q2 results on October 29.</li><li>Commvault shares are <font color=\"green\">up 2.6%</font> to $45.31.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503799\" data-linked=\"Commvault +2.6% on raised Q2 view\" data-tweet=\"$CVLT - Commvault +2.6% on raised Q2 view https://seekingalpha.com/news/3503799-commvaultplus-2_6-on-raised-q2-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3503799-commvaultplus-2_6-on-raised-q2-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503798\" data-ts=\"1570121039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503798-netflix-earnings-on-radar-of-analysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix earnings on the radar of analysts</a></h4><ul> <li>Bank of America Merrill Lynch is out with an early earnings preview on Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='red'>-1.1%</font>) that tilts to the cautious side.</li> <li>\"We see a make or break quarter for Netflix in the wake of a 25%+ sell-off since 2Q paid subscriber adds trailed Netflix\u2019s own guidance. While Netflix has never missed its own guidance two quarters in a row, we flag the company\u2019s CFO transition as a risk, because at this point,\" write analyst Nat Schindler and team.</li> <li>BAML sticks with a Buy rating on Netflix as it notes valuation on a price-to-sales multiple is below video game companies and with contribution margins increasing.</li> <li>Netflix is due to report earnings on October 16.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3503798\" data-linked=\"Netflix earnings on the radar of analysts\" data-tweet=\"$NFLX - Netflix earnings on the radar of analysts https://seekingalpha.com/news/3503798-netflix-earnings-on-radar-of-analysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3503798-netflix-earnings-on-radar-of-analysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503795\" data-ts=\"1570120440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NET\" target=\"_blank\">NET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503795-hedgeye-adds-cloudflare-to-best-ideas-list-netminus-2_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye adds Cloudflare to best ideas list; NET -2.8%</a></h4><ul><li>Hedgeye adds Cloudflare (NYSE:<a href='https://seekingalpha.com/symbol/NET' title='Cloudflare, Inc.'>NET</a>) to its best ideas long list, according to Bloomberg.</li><li>The firm sees the potential for a 50% upside.</li><li>NET shares are up <font color=\"red\">down 2.8%</font> to $16.78.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503795\" data-linked=\"Hedgeye adds Cloudflare to best ideas list; NET -2.8%\" data-tweet=\"$NET - Hedgeye adds Cloudflare to best ideas list; NET -2.8% https://seekingalpha.com/news/3503795-hedgeye-adds-cloudflare-to-best-ideas-list-netminus-2_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3503795-hedgeye-adds-cloudflare-to-best-ideas-list-netminus-2_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503790\" data-ts=\"1570119260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503790-snapminus-5-facebook-rolls-out-camera-messaging-app\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap -5% as Facebook rolls out camera/messaging app</a></h4><ul>   <li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) has made a sudden leg down, <font color=\"red\">-5.5%</font>, after Instagram (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+1.5%</font>) announces worldwide availability of its \"new <a href=\"https://newsroom.fb.com/news/2019/10/introducing-threads/\" target=\"_blank\">camera-first messaging app</a>.\"</li>    <li>Targeted at a \"smaller circle of friends\" than Instagram's other visual sharing efforts, the new Threads is a stand-alone app aimed at privacy and speed.</li>    <li>\"You can share photos, videos, messages, Stories and more with your Instagram close friends list,\" Facebook says of the new app. \"You are in control of who can reach you on Threads, and you can customize the experience around the people who matter most.\"</li>    <li>It begins global rollout today.</li><li>Snap shares <a href=\"https://seekingalpha.com/news/3495008-snap-minus-4_5-percent-instagram-tests-close-friends-app\" target=\"_blank\">similarly dipped in August </a>on reports that Facebook was working on the Threads app.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503790\" data-linked=\"Snap -5% as Facebook rolls out camera/messaging app\" data-tweet=\"$SNAP $FB - Snap -5% as Facebook rolls out camera/messaging app https://seekingalpha.com/news/3503790-snapminus-5-facebook-rolls-out-camera-messaging-app?source=tweet\" data-url=\"https://seekingalpha.com/news/3503790-snapminus-5-facebook-rolls-out-camera-messaging-app\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503785\" data-ts=\"1570118453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503785-tata-motors-among-consumer-gainers-gopro-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors among consumer gainers; GoPro leads the losers</a></h4><ul><li><b>Gainers: </b>China XD Plastics (NASDAQ:<a href='https://seekingalpha.com/symbol/CXDC' title='China XD Plastics Company Limited'>CXDC</a>) <font color=\"green\">+8%</font>. RiceBran Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/RIBT' title='RiceBran Technologies'>RIBT</a>) <font color=\"green\">+7%</font>. Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <font color=\"red\">-20%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"red\">-8%</font>. VOXX International (NASDAQ:<a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corporation'>VOXX</a>) <font color=\"red\">-7%</font>. American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>) <font color=\"red\">-7%</font>. Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503785\" data-linked=\"Tata Motors among consumer gainers; GoPro leads the losers\" data-tweet=\"$CXDC $RIBT $TTM - Tata Motors among consumer gainers; GoPro leads the losers https://seekingalpha.com/news/3503785-tata-motors-among-consumer-gainers-gopro-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503785-tata-motors-among-consumer-gainers-gopro-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503775\" data-ts=\"1570116383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503775-u-s-crude-oil-lower-for-eighth-straight-session\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. crude oil lower for eighth straight session</a></h4><ul><li>Equities have snapped back from sharp early losses but not so much for crude oil (<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color=\"red\">-1.1%</font>), as WTI is <a href=\"https://www.marketwatch.com/story/us-oil-down-for-8th-straight-session-as-demand-worries-grow-2019-10-03\" target=\"_blank\">on track for its eighth straight down day</a> amid concerns about global economic growth, oil demand and signs of excess supply; November WTI <font color=\"red\">-1.4%</font> to $51.89/bbl.</li><li>The drop in the ISM service sector index \"to the weakest growth in three years gave rise to further concerns for an economic slowdown in the U.S., so it's largely a demand-driven decline\u201d for crude, IHS Markit energy analyst Marshall Steeves tells <em>MarketWatch</em>.</li><li>\"It is simply impossible to predict where the next significant price  support will come from, as the focus is firmly on economic developments, and those are <a href=\"https://www.cnbc.com/2019/10/03/oil-markets-global-economy-in-focus.html\" target=\"_blank\">anything but optimistic,</a>\" according to Tamas Varga of oil broker PVM.</li><li>Saudi Arabia energy minister Prince Abdulaziz bin Salman says the country has <a href=\"https://www.reuters.com/article/russia-oil-opec-sarabia/saudi-arabia-says-it-has-fully-restored-oil-output-after-attacks-idUSS8N1YC01W\" target=\"_blank\">fully restored production</a> after last month's attacks on its  facilities and is now focusing on Aramco's listing.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3503775\" data-linked=\"U.S. crude oil lower for eighth straight session\" data-tweet=\"$USO $XLE $OIL - U.S. crude oil lower for eighth straight session https://seekingalpha.com/news/3503775-u-s-crude-oil-lower-for-eighth-straight-session?source=tweet\" data-url=\"https://seekingalpha.com/news/3503775-u-s-crude-oil-lower-for-eighth-straight-session\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503767\" data-ts=\"1570114861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503767-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+17%</font>. Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"green\">+11%</font>. Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) <font color=\"green\">+12%</font>. Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) <font color=\"green\">+10%</font>. Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>Enlivex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ENLV' title='Enlivex Therapeutics Ltd.'>ENLV</a>) <font color=\"red\">-44%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-20%</font>. AngioDynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a>) <font color=\"red\">-16%</font>. Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals, Inc.'>PGNX</a>) <font color=\"red\">-9%</font>. Mesoblast (NASDAQ:<a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast Limited'>MESO</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503767\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$PDSB $OBLN $GLMD - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3503767-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503767-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503768\" data-ts=\"1570114700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTM\" target=\"_blank\">VSTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503768-verastemplus-4_9-on-orphan-drug-designation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verastem +4.9% on Orphan Drug designation</a></h4><ul><li>The FDA <a href=\"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=703019\" target=\"_blank\">grants </a>Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) the designation for duvelisib for the treatment of T-Cell Lymphoma.</li><li>VSTM shares are <font color=\"green\">up 4.9%</font> to $1.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503768\" data-linked=\"Verastem +4.9% on Orphan Drug designation\" data-tweet=\"$VSTM - Verastem +4.9% on Orphan Drug designation https://seekingalpha.com/news/3503768-verastemplus-4_9-on-orphan-drug-designation?source=tweet\" data-url=\"https://seekingalpha.com/news/3503768-verastemplus-4_9-on-orphan-drug-designation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503762\" data-ts=\"1570113881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TORXF\" target=\"_blank\">TORXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503762-torex-golds-q3-production-hits-record\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Torex Gold&#39;s Q3 production hits record</a></h4><ul><li>Torex Gold Resources (<a href='https://seekingalpha.com/symbol/TORXF' title='Torex Gold Resources Inc'>OTCPK:TORXF</a> <font color='green'>+5.6%</font>) reports <a href=\"https://seekingalpha.com/pr/17652075-torex-gold-establishes-new-quarterly-production-record-138100-ounces-gold\" target=\"_blank\">record quarterly gold production</a> of 138.1K oz. in Q3, topping its previous record set in Q2 by 21%, with sales of 132.5K oz. at an average realized price of $1,475/oz.</li><li>Torex says it is on track to achieve full-year guidance of 430K oz. of gold sales after selling 322.4K oz. during the first nine months of the year at an average realized price of $1,376/oz.</li><li>The miner also says its total cash balance increased by $52M and total debt was reduced by $36M during the quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503762\" data-linked=\"Torex Gold&#39;s Q3 production hits record\" data-tweet=\"$TORXF - Torex Gold&#39;s Q3 production hits record https://seekingalpha.com/news/3503762-torex-golds-q3-production-hits-record?source=tweet\" data-url=\"https://seekingalpha.com/news/3503762-torex-golds-q3-production-hits-record\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503758\" data-ts=\"1570113038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503758-natural-gas-inventory-build-slightly-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build slightly more than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+112 Bcf</strong> vs. +105 Bcf consensus, +102 Bcf last week.</li><li>Futures <font color=\"red\">-0.45%</font> to $2.237.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503758\" data-linked=\"Natural gas inventory build slightly more than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build slightly more than consensus https://seekingalpha.com/news/3503758-natural-gas-inventory-build-slightly-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3503758-natural-gas-inventory-build-slightly-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503757\" data-ts=\"1570112949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RECN\" target=\"_blank\">RECN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503757-resources-connection-slips-17-post-q1-mixed-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Resources Connection slips 17% post Q1 mixed results</a></h4><ul><li>Resources Connection (<a href='https://seekingalpha.com/symbol/RECN' title='Resources Connection, Inc.'>RECN</a> <font color=\"red\">-17.1%</font>) reported Q1 revenue decline of 3.5% Y/Y to $172.23M, reflecting the impact of reduced client demand in the Nordics and the wind-down of technical accounting implementation projects.</li><li>Revenue by geography: North America $140.37M (-3.9% Y/Y); Asia Pacific $13.09M (+11.8% Y/Y); and Europe $18.76M (-9.3% Y/Y).</li><li>Q1 Gross margin <font color=\"green\">expanded by 103 bps</font> to 39.2%, reflecting improved bill/pay ratio.</li><li>Q1 Operating margin <font color=\"red\">declined by 80 bp</font>s to 4.7%.</li><li>Adj. EBITDA was $11.91M (-10.1% Y/Y) and margin <font color=\"red\">declined by 50 bps</font> to 6.9%.</li><li>SG&amp;A expenses were $56.97M (+1.1% Y/Y); and as percentage of revenues 33.1% up by 152 bps, reflecting higher payroll and benefits costs.</li><li>Cash flow from operating activities was negative $3.04M, compared to negative $16.6M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3503514-resources-connection-eps-beats-0_02-misses-revenue\" target=\"_blank\">Resources Connection EPS beats by $0.02, misses on revenue</a> (Oct. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3503757\" data-linked=\"Resources Connection slips 17% post Q1 mixed results\" data-tweet=\"$RECN - Resources Connection slips 17% post Q1 mixed results https://seekingalpha.com/news/3503757-resources-connection-slips-17-post-q1-mixed-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3503757-resources-connection-slips-17-post-q1-mixed-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503756\" data-ts=\"1570112661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNFI\" target=\"_blank\">UNFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503756-pivotal-research-expects-united-natural-foods-to-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal Research expects United Natural Foods to fall further</a></h4><ul> <li>Pivotal Research doubles down on its Sell rating on United Natural Foods (<a href='https://seekingalpha.com/symbol/UNFI' title='United Natural Foods, Inc.'>UNFI</a> <font color='red'>-4.5%</font>) and view that the company faces an existential threat.</li> <li>Analyst Ajay Jain and team dig deep into UNFI's guidance in making the assessment: \"We\u2019ve gotten clarification that management\u2019s debt reduction target of $200-$300 million includes all proceeds for retail including Cub Foods (as well as Shoppers Food which is now excluded from earnings completely). We think it may still be lost on some investors that while Cub revenue and earnings are included in the full year FY20 guidance, mgt. also assumes the benefit from the sale of Cub with its net debt and interest assumptions for FY20. This is a glaring inconsistency, in our view.\"</li> <li>Pivotal drops its price target on UNFI to $3 from $6 (6X EV/EBITDA), well-below the <a href=\"https://seekingalpha.com/symbol/UNFI/ratings/sell-side-ratings\" target=\"_blank\">consensus sell-side PT</a> of $8.96.</li><li>United Natural Foods is down sharply for a second day in a row.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3503497-confidence-fades-united-natural-foods\" target=\"_blank\">Confidence fades in United Natural Foods</a> (Oct. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503756\" data-linked=\"Pivotal Research expects United Natural Foods to fall further\" data-tweet=\"$UNFI - Pivotal Research expects United Natural Foods to fall further https://seekingalpha.com/news/3503756-pivotal-research-expects-united-natural-foods-to-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3503756-pivotal-research-expects-united-natural-foods-to-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503747\" data-ts=\"1570111312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503747-deutsche-lifts-alphabet-on-cloud-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche lifts Alphabet on Cloud confidence</a></h4><ul><li>Deutsche Bank increases its Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='red'>-0.9%</font>) target from $1,475 to $1,600 and maintains a Buy rating.</li><li>The firm cites increasing confidence around Google Cloud.</li><li>Alphabet has an Outperform average<a href=\"https://seekingalpha.com/symbol/GOOG/ratings/sell-side-ratings#filter=all\" target=\"_blank\"> Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503747\" data-linked=\"Deutsche lifts Alphabet on Cloud confidence\" data-tweet=\"$GOOG $GOOGL - Deutsche lifts Alphabet on Cloud confidence https://seekingalpha.com/news/3503747-deutsche-lifts-alphabet-on-cloud-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3503747-deutsche-lifts-alphabet-on-cloud-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503745\" data-ts=\"1570111232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503745-ism-services-slides-to-three-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISM services slides to three-year low</a></h4><ul><li><a href=\"https://www.instituteforsupplymanagement.org/ISMReport/NonMfgROB.cfm?navItemNumber=12943\" target=\"_blank\">September ISM Non-Manufacturing Index</a>: 52.6<strong> </strong>vs. 55.5 consensus, 56.4 prior. That's the lowest print since August 2016.</li><li>Business activity 55.2% vs 61.5.</li><li>New Orders 53.7% vs 60.3.</li><li>Employment 50.4% vs 53.1.</li><li>The 10-year Treasury yield knee-jerks lower by six basis points to 1.53%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"green\">+0.8%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"red\">-1.6%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3503745\" data-linked=\"ISM services slides to three-year low\" data-tweet=\"$TLT $TBT - ISM services slides to three-year low https://seekingalpha.com/news/3503745-ism-services-slides-to-three-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3503745-ism-services-slides-to-three-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503744\" data-ts=\"1570110990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503744-delta-falls-again-after-buckingham-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta falls again after Buckingham downgrade</a></h4><ul> <li>Buckingham Research <a href=\"https://twitter.com/BuckResearch/status/1179719805907197953\" target=\"_blank\">lowers</a> Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color=\"red\">-2.9%</font>) to a Neutral rating from Buy due to the challenging cost outlook.</li><li>The firm anticipates consensus estimates for FY20 will start to be lowered. As it stands now, Delta is a <a href=\"https://seekingalpha.com/symbol/DAL/ratings/sell-side-ratings\" target=\"_blank\">consensus Outperform rating</a> on Wall Street.</li> <li>Shares of Delta are down for a second straight today after the airline company's update <a href=\"https://seekingalpha.com/news/3503438-deltas-costs-update-hangs-airline-sector\" target=\"_blank\">rattled</a> the entire sector.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3503744\" data-linked=\"Delta falls again after Buckingham downgrade\" data-tweet=\"$DAL - Delta falls again after Buckingham downgrade https://seekingalpha.com/news/3503744-delta-falls-again-after-buckingham-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3503744-delta-falls-again-after-buckingham-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503732\" data-ts=\"1570109399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRWD\" target=\"_blank\">CRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503732-crowdstrikeplus-4_5-suntrust-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CrowdStrike +4.5% as SunTrust turns bullish</a></h4><ul><li>CrowdStrike (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) is upgraded from Hold to Buy at SunTrust with the price target maintained at $80.</li><li>Analyst Joel Fishbein Jr. cites CRWD showing the \"fastest growth rate at scale of any company under our coverage.\"</li><li>Fishbein highlights the 94% Y/Y revenue growth with subscription revenue up 98%. The analyst expects sales to continue to rise 40%+.</li><li>CRWD shares are <font color=\"green\">up 4.5%</font> pre-market to $59.19. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/CRWD/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503732\" data-linked=\"CrowdStrike +4.5% as SunTrust turns bullish\" data-tweet=\"$CRWD - CrowdStrike +4.5% as SunTrust turns bullish https://seekingalpha.com/news/3503732-crowdstrikeplus-4_5-suntrust-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3503732-crowdstrikeplus-4_5-suntrust-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503729\" data-ts=\"1570109340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503729-ascena-retail-volatile-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascena Retail volatile ahead of earnings</a></h4><ul> <li>Ascena Retail Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group, Inc.'>ASNA</a>) is trading wildly in front of today's earnings report due out after the closing bell.</li> <li>Shares of the sub-$1 retail stock are <font color=\"green\">up 4.46%</font> premarket after being up more than 20% earlier. Premarket volume on ASNA is over 107K.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3503729\" data-linked=\"Ascena Retail volatile ahead of earnings\" data-tweet=\"$ASNA - Ascena Retail volatile ahead of earnings https://seekingalpha.com/news/3503729-ascena-retail-volatile-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3503729-ascena-retail-volatile-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503724\" data-ts=\"1570108627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503724-aristaminus-2_8-nomura-cuts-on-tough-comps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista -2.8% as Nomura cuts on tough comps</a></h4><ul>   <li>Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) is <font color=\"red\">2.8% lower</font> premarket after a cut to Neutral at Nomura, which is looking toward difficult comps for the company in the first half of 2020 and webscale challenges.</li>    <li>Recovery may be \"elusive,\" the firm says, with potential share loss in webscale in the second half of '20. A forecast for low single digit webscale growth in the second half of this year is likely \"overly prudent\" in the long term.</li>    <li>It's cut its price target to $230 from $290, implying just 0.7% upside from yesterday's close of $228.33.</li>    <li>Sell-side analysts on average <a href=\"https://seekingalpha.com/symbol/ANET/ratings/sell-side-ratings\" target=\"_blank\">rate it Outperform</a>, and <a href=\"https://seekingalpha.com/symbol/ANET/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Bullish</a> overall. The stock has a <a href=\"https://seekingalpha.com/symbol/ANET/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3503724\" data-linked=\"Arista -2.8% as Nomura cuts on tough comps\" data-tweet=\"$ANET - Arista -2.8% as Nomura cuts on tough comps https://seekingalpha.com/news/3503724-aristaminus-2_8-nomura-cuts-on-tough-comps?source=tweet\" data-url=\"https://seekingalpha.com/news/3503724-aristaminus-2_8-nomura-cuts-on-tough-comps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503723\" data-ts=\"1570108380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBLN\" target=\"_blank\">OBLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503723-obalon-up-14-premarket-on-debt-repayment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obalon up 14% premarket on debt repayment</a></h4><ul> <li>Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) has <a href=\"https://seekingalpha.com/pr/17652669-obalon-announces-repayment-long-term-debt-regaining-compliance-nasdaq-listing-requirement\" target=\"_blank\">retired</a> the remaining $5M of its long-term debt facility with Pacific Western Bank.</li><li>The debt payoff eliminates interest expense of ~$350,000 annually.</li><li>Separately, in an 8-K filing the company announced that it has regained Nasdaq listing compliance by increasing its stockholder\u2019s equity.</li><li>Shares are up <font color=\"green\">14%</font> premarket.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3503723\" data-linked=\"Obalon up 14% premarket on debt repayment\" data-tweet=\"$OBLN - Obalon up 14% premarket on debt repayment https://seekingalpha.com/news/3503723-obalon-up-14-premarket-on-debt-repayment?source=tweet\" data-url=\"https://seekingalpha.com/news/3503723-obalon-up-14-premarket-on-debt-repayment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503722\" data-ts=\"1570108224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELTF\" target=\"_blank\">CELTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503722-centamin-ceo-pardey-to-retire-misses-production-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centamin CEO Pardey to retire; misses production target</a></h4><ul><li>Centamin (<a href='https://seekingalpha.com/symbol/CELTF' title='Centamin plc'>OTCPK:CELTF</a>) says CEO Andrew Pardey plans to <a href=\"https://www.proactiveinvestors.co.uk/companies/news/904081/centamin-boss-retires-as-gold-miner-misses-production-target-904081.html\" target=\"_blank\">leave the company next year</a> after 12 years at the miner; shares <font color=\"red\">-13%</font> in London trading.</li><li>Centamin also says its YTD production is lower than expected at 331K-332K oz., although the lower  end of its full-year guidance range of 490K oz. \"remains  achievable.\"</li><li>The company expects Q3 gold production of 97K-98K oz., due to reduced open pit mining rates on the higher-grade stage 4  west wall.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503722\" data-linked=\"Centamin CEO Pardey to retire; misses production target\" data-tweet=\"$CELTF - Centamin CEO Pardey to retire; misses production target https://seekingalpha.com/news/3503722-centamin-ceo-pardey-to-retire-misses-production-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3503722-centamin-ceo-pardey-to-retire-misses-production-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503721\" data-ts=\"1570107977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503721-gpro-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GPRO among premarket losers</a></h4><ul><li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-23%</font>.</li><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <font color=\"red\">-18%</font> after announcing updated FY 2019 <a href=\"https://seekingalpha.com/news/3503618-gopro-minus-14-percent-trims-2019-guidance\" target=\"_blank\">guidance</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503721\" data-linked=\"GPRO among premarket losers\" data-tweet=\"$JAGX $GPRO - GPRO among premarket losers https://seekingalpha.com/news/3503721-gpro-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503721-gpro-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503719\" data-ts=\"1570107862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503719-thin-ranks-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thin ranks among premarket gainers</a></h4><ul><li>NanoViricides (NYSEMKT:<a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/pr/17652227-nanoviricides-creating-nanomedicines-develop-antiviral-therapies-combat-shingles-herpes\" target=\"_blank\">announcement</a> that its first clinical drug candidate, NV-HHV-101, for the treatment of the Shingles virus (aka VZV), is on track with required preclinical GLP Safety and Toxicology studies moving towards human clinical trials.</li><li>Savara (NASDAQ:<a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a>) <font color=\"green\">+8%</font>.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+6%</font>.</li><li>The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3503705-meet-group-plus-5-percent-raised-q3-outlook\" target=\"_blank\">raised Q3 outlook</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503719\" data-linked=\"Thin ranks among premarket gainers\" data-tweet=\"$NNVC $SVRA $TTM - Thin ranks among premarket gainers https://seekingalpha.com/news/3503719-thin-ranks-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3503719-thin-ranks-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503705\" data-ts=\"1570106265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503705-meet-groupplus-5-on-raised-q3-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meet Group +5% on raised Q3 outlook</a></h4><ul><li>The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <a href=\"https://seekingalpha.com/pr/17652260-meet-group-announces-selected-preliminary-financial-results-third-quarter-2019\" target=\"_blank\">provides</a> preliminary Q3 results that includes revenue of $52M to $52.3M (was: $50.5-51M; consensus: $50.7M).</li><li>Adjusted EBITDA is expected between $10.4-10.6M (was: $9.3-9.5M)</li><li>The company will report Q3 results next month.</li><li>MEET shares are <font color=\"green\">up 5.1%</font> pre-market to $3.32.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503705\" data-linked=\"Meet Group +5% on raised Q3 outlook\" data-tweet=\"$MEET - Meet Group +5% on raised Q3 outlook https://seekingalpha.com/news/3503705-meet-groupplus-5-on-raised-q3-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3503705-meet-groupplus-5-on-raised-q3-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503704\" data-ts=\"1570106076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503704-tesla-on-hot-seat-after-deliveries-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla on the hot seat after deliveries report</a></h4><ul> <li>Wedbush Securities analyst Dan Ives sees Tesla's (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) Q3 deliveries report as a step in the right direction.</li> <li>\"The most important number in the release was the key Model 3 deliveries which came in at 79,600 and were above the Street\u2019s 77,010 estimate as this remains the linchpin of the Tesla growth story for the coming years,\" says Ives.</li> <li>\"While the doomsday scenario is off the table with cash in the coffer (convert) and Model 3 sales ramping, the question on the minds of investors is around profits into 2020. The stock will be range-bound in our opinion until Musk &amp; Co. update the Street with the financial results, profitability picture, and 4Q guidance later this month trying to regain the credibility of the Street,\" he adds.</li> <li>Wedbush sticks with a Neutral rating on Tesla and price target of $220.</li> <li>Elsewhere on Wall Street: JMP Securities lowers Tesla to a Market Perform rating from Outperform. The firm says it's concerned that demand for Tesla cars is levelling off. \"We know of no operational issues that could have prevented TSLA from delivering more vehicles if demand were available,\" notes the firm.The <a href=\"https://seekingalpha.com/symbol/TSLA/ratings/sell-side-ratings\" target=\"_blank\">consensus sell-side rating</a> on Tesla is Hold.</li>  <li>Shares of Tesla are <font color=\"red\">down 4.73%</font> premarket to $231.73.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3503594-tesla-minus-5-percent-q3-deliveries-fall-short-100k\" target=\"_blank\">Tesla -5% after Q3 deliveries fall short of 100K</a> (Oct. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503704\" data-linked=\"Tesla on the hot seat after deliveries report\" data-tweet=\"$TSLA - Tesla on the hot seat after deliveries report https://seekingalpha.com/news/3503704-tesla-on-hot-seat-after-deliveries-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3503704-tesla-on-hot-seat-after-deliveries-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>360&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503699\" data-ts=\"1570105340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503699-netflix-inks-movie-deal-in-italy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix inks movie deal in Italy</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) plans to make <a href=\"https://www.bloomberg.com/news/articles/2019-10-03/netflix-to-make-movies-in-italy-with-berlusconi-s-mediaset\" target=\"_blank\">movies</a> with Italian broadcaster Mediaset SpA as it looks to add subscribers in Italy.</li> <li>Netflix will contribute most of the financing for the seven titles in the hopper.</li> <li>CEO Reed Hastings is expected to formally announce more details on the deal in Rome next week.</li><li>NFLX <font color=\"red\">-0.99%</font> premarket to $265.52.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503699\" data-linked=\"Netflix inks movie deal in Italy\" data-tweet=\"$NFLX - Netflix inks movie deal in Italy https://seekingalpha.com/news/3503699-netflix-inks-movie-deal-in-italy?source=tweet\" data-url=\"https://seekingalpha.com/news/3503699-netflix-inks-movie-deal-in-italy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503695\" data-ts=\"1570104887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503695-constellation-brandsminus-4-after-earnings-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands -4% after earnings disappoint</a></h4><ul> <li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) reports beer sales of $1.64B in <a href=\"https://seekingalpha.com/news/3503678-constellation-brands-eps-beats-0_29-revenue-line\" target=\"_blank\">Q2</a> on 5.3% shipments growth and wine/spirits sales of $704M on a shipments drop of 10%.</li> <li>Gross margin came in at 51.4% of sales vs. 51.9% consensus. Operating margin was 33.8% of sales vs. 33.4% consensus.</li> <li>Constellation's says it share of Canopy Growth equity losses were $484M.</li> <li>Looking ahead, the company sees full-year EPS of $9.00 to $9.20 vs. $8.65 to $8.95 prior and free cash flow of $1.3B to $1.4B.</li> <li>Shares of STZ are <font color=\"red\">down 3.72%</font> in premarket trading to $199.10.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3503678-constellation-brands-eps-beats-0_29-revenue-line\" target=\"_blank\">Constellation Brands EPS beats by $0.29,  revenue in-line</a> (Oct. 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503695\" data-linked=\"Constellation Brands -4% after earnings disappoint\" data-tweet=\"$STZ - Constellation Brands -4% after earnings disappoint https://seekingalpha.com/news/3503695-constellation-brandsminus-4-after-earnings-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3503695-constellation-brandsminus-4-after-earnings-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503677\" data-ts=\"1570102709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNNMY\" target=\"_blank\">HNNMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503677-hennes-mauritzplus-6-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hennes &amp; Mauritz +6% after strong quarter</a></h4><ul> <li>Hennes &amp; Mauritz AB (<a href='https://seekingalpha.com/symbol/HNNMY' title='H & M Hennes & Mauritz AB &#40;publ&#41;'>OTCPK:HNNMY</a>) rallies after <a href=\"https://www.marketwatch.com/story/hm-profit-beats-forecasts-as-collections-score-a-hit-with-shoppers-2019-10-03\" target=\"_blank\">posting</a> profit of 3.9B Swedish kronor in Q3 vs. 3.1B Swedish kronor a year ago. It was the first time in two years that H&amp;M increased quarterly profit.</li> <li>\"The continued development of more full-price sales and reduced markdowns contributed to a 26% increase in operating profit in the third quarter, all while maintaining a high level of activity in our transformation work,\" notes  CEO Karl-Johan Persson on the quarter.</li>  <li>Shares of H&amp;M are <font color=\"green\">up 6.31%</font> in Stockholm trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3503677\" data-linked=\"Hennes &amp; Mauritz +6% after strong quarter\" data-tweet=\"$HNNMY - Hennes &amp; Mauritz +6% after strong quarter https://seekingalpha.com/news/3503677-hennes-mauritzplus-6-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3503677-hennes-mauritzplus-6-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503671\" data-ts=\"1570102103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMMT\" target=\"_blank\">SMMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503671-summit-therapeutics-up-17-premarket-on-positive-ridinilazole-data-in-cdi-patients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit Therapeutics up 17% premarket on positive ridinilazole data in CDI patients</a></h4><ul> <li>Summit Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>) is up <font color=\"green\">17%</font> premarket on  <a href=\"https://seekingalpha.com/pr/17652136-summit-therapeutics-reports-ridinilazole-significantly-improved-short-longer-term-quality\" target=\"_blank\">announcing</a> results from the Phase 2 clinical trial of ridinilazole in <em>C. difficile</em> infection (\u2018CDI\u2019) detailing improvements in patient quality of life following antibiotic treatment for CDI.</li>            <li>The trial evaluated ridinilazole compared to vancomycin in 100 patients.</li>        <li>The number of patients treated with ridinilazole reporting problems in this measure decreased throughout the timepoints.</li><li>At Day five, patients treated with ridinilazole reported significant improvements in index scores (p=0.008).</li><li>By Day 10, numerically fewer patients treated with ridinilazole reported issues than those treated with vancomycin.</li><li>Overall, statistically significant improvements were observed in physical and mental health measures.</li>        </ul><div class=\"tiny-share-widget\" data-id=\"3503671\" data-linked=\"Summit Therapeutics up 17% premarket on positive ridinilazole data in CDI patients\" data-tweet=\"$SMMT - Summit Therapeutics up 17% premarket on positive ridinilazole data in CDI patients https://seekingalpha.com/news/3503671-summit-therapeutics-up-17-premarket-on-positive-ridinilazole-data-in-cdi-patients?source=tweet\" data-url=\"https://seekingalpha.com/news/3503671-summit-therapeutics-up-17-premarket-on-positive-ridinilazole-data-in-cdi-patients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503670\" data-ts=\"1570102067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503670-ubs-sees-22-share-for-potential-feye-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS sees $22/share for potential FEYE sale</a></h4><ul><li>UBS analyst Fatima Boolani weighs in after yesterday's <a href=\"https://seekingalpha.com/news/3503494-fireeye-plus-5_4-percent-report-mulling-sale\" target=\"_blank\">Business Insider report</a> that FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) is considering a sale.</li><li>Boolani calculates a sum-of-the-parts valuation of $22 per share, using a 5x CY20 estimate of Enterprise value/sales multiple.</li><li>FEYE is currently trading at 3x CY20 EV/S compared to the 2x-5x range for recent PE-led security deals, including Imperva and Barracuda Networks.</li><li>UBS maintains a Neutral rating and $15.50 price target. FEYE has an Outperform average <a href=\"https://seekingalpha.com/symbol/FEYE/ratings/sell-side-ratings?s=feye\" target=\"_blank\">Sell Side rating</a>.</li><li>FireEye shares are <font color=\"green\">up 1.3%</font> pre-market to $14.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503670\" data-linked=\"UBS sees $22/share for potential FEYE sale\" data-tweet=\"$FEYE - UBS sees $22/share for potential FEYE sale https://seekingalpha.com/news/3503670-ubs-sees-22-share-for-potential-feye-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3503670-ubs-sees-22-share-for-potential-feye-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503651\" data-ts=\"1570098054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503651-pepsico-beat-q3-estimates-and-reaffirms-fy2019-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo beat Q3 estimates and reaffirms FY2019 outlook</a></h4><ul><li>PepsiCo (NASDAQ:<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo, Inc.'>PEP</a>) reports organic revenue growth of 4.3% in <a href=\"https://www.pepsico.com/docs/album/investors/q3-2019/q3-2019-earnings-release_t7s7ou4f4zkl3amo.pdf\" target=\"_blank\">Q3</a>.</li><li>Foreign exchange impact on revenue was -1%.</li><li>Revenue by segment: Frito-Lay North America: $4.11B (+5.5%); Quaker Foods North America: $576M (+1.5%); Latin America: $1.90B (+2%); North America Beverages: $5.64B (+3.5%); Europe Sub-Saharan Africa: $3.35B (+6%); AMENA: $1.61B (+5%).</li><li>Total core gross margin rate improved 90 bps to 55.4%.</li><li>Total core operating margin rate down 40 bps to 17.2%.</li><li><b>FY2019 Guidance</b>: Organic revenue growth: Meet or exceed 4%; Core EPS: $5.50; Tax rate: ~21%; Net capital expenditure: ~$4.5B; Cash flow from operating activities: ~$9B; Free cash flow: ~$5B.</li><li>PEP<font color=\"red\"> </font><font color=\"red\">-0.07%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3503650-pepsico-eps-beats-0_05-beats-revenue\" target=\"_blank\">PepsiCo EPS beats by $0.05, beats on revenue</a> (Oct. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3503651\" data-linked=\"PepsiCo beat Q3 estimates and reaffirms FY2019 outlook\" data-tweet=\"$PEP - PepsiCo beat Q3 estimates and reaffirms FY2019 outlook https://seekingalpha.com/news/3503651-pepsico-beat-q3-estimates-and-reaffirms-fy2019-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3503651-pepsico-beat-q3-estimates-and-reaffirms-fy2019-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3503639\" data-ts=\"1570095887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3503639-futures-point-to-slight-turnaround\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures point to slight turnaround</a></h4><ul><li>Wall Street is looking to recover from an 800-point plunge over the last two sessions as investors track fears of an economic recession and latest tariff ruling from the WTO.</li><li>After Tuesday's dire picture on manufacturing from the ISM, investors now await today's ISM services report and tomorrow's non-farm payrolls data to confirm or quash  concerns about world economic growth.</li><li>Ahead of the release, U.S. stock index futures indicate a higher open, with the Dow <font color=\"green\">ahead by 88 points</font>, and S&amp;P 500 and Nasdaq up <font color=\"green\">0.4% and 0.5%</font>, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3503639\" data-linked=\"Futures point to slight turnaround\" data-tweet=\"Futures point to slight turnaround https://seekingalpha.com/news/3503639-futures-point-to-slight-turnaround?source=tweet\" data-url=\"https://seekingalpha.com/news/3503639-futures-point-to-slight-turnaround\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":62,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}